Modularly designed peptide-based nanomedicine inhibits angiogenesis to enhance chemotherapy for post-surgical recurrence of esophageal squamous cell carcinomas

[1]  Zhenzhong Zhang,et al.  Biomimetic Micelles to Accurately Regulate the Inflammatory Microenvironment for Glomerulonephritis Treatment. , 2022, Pharmacological research.

[2]  Pegah Zanjanchi,et al.  Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity , 2022, Journal of Nanobiotechnology.

[3]  J. Cho,et al.  Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3. , 2021, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  D. Spring,et al.  Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs). , 2020, Chemical Society reviews.

[5]  Y. Tu,et al.  The birth of artemisinin. , 2020, Pharmacology & therapeutics.

[6]  Jia-xu Chen,et al.  Natural products and their derivatives: Promising modulators of tumor immunotherapy , 2020, Journal of leukocyte biology.

[7]  Q. Shen,et al.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance , 2020, Genes & diseases.

[8]  Mohammad Aslam Khan,et al.  Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy. , 2020, Seminars in cancer biology.

[9]  L. Ren,et al.  Modularly Designed Peptide Nanoprodrug Augments Anti-Tumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2, 3-Dioxygenase. , 2020, Journal of the American Chemical Society.

[10]  Anping Li,et al.  Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy , 2019, Journal of Hematology & Oncology.

[11]  Xuexiang Han,et al.  Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy , 2019, Advanced materials.

[12]  Asghar Fallah,et al.  Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  M. Safa,et al.  Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway. , 2018, Biochimica et biophysica acta. General subjects.

[14]  Shi Liu,et al.  Sandwich‐Like Fibers/Sponge Composite Combining Chemotherapy and Hemostasis for Efficient Postoperative Prevention of Tumor Recurrence and Metastasis , 2018, Advanced materials.

[15]  A. Parikh,et al.  Assessment of the risk of antiangiogenic agents before and after surgery. , 2018, Cancer treatment reviews.

[16]  C. Abnet,et al.  Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.

[17]  T. Efferth.  From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. , 2017, Seminars in cancer biology.

[18]  Honggang Cui,et al.  Peptide–drug conjugates as effective prodrug strategies for targeted delivery , 2017, Advanced drug delivery reviews.

[19]  Jia Zhou,et al.  Discovery and development of natural product oridonin-inspired anticancer agents. , 2016, European journal of medicinal chemistry.

[20]  A. Azab,et al.  Anti-Inflammatory Activity of Natural Products , 2016, Molecules.

[21]  Jia Zhou,et al.  Discovery and Development of Natural Product Oridonin‐Inspired Anticancer Agents , 2016 .

[22]  Gordon C Jayson,et al.  Antiangiogenic therapy in oncology: current status and future directions , 2016, The Lancet.

[23]  Osamu Kikuchi,et al.  Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. , 2015, Gastroenterology.

[24]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[25]  T. Ji,et al.  Peptide Assembly Integration of Fibroblast‐Targeting and Cell‐Penetration Features for Enhanced Antitumor Drug Delivery , 2015, Advanced materials.

[26]  Y. Ohkura,et al.  Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[27]  L. Mascitelli,et al.  Surgery and cancer promotion: are we trading beauty for cancer? , 2011, QJM : monthly journal of the Association of Physicians.

[28]  Ning Kang,et al.  Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. , 2010, Cancer letters.

[29]  Q. Guo,et al.  Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. , 2008, Biomaterials.

[30]  Ming Yan,et al.  Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. , 2007, Blood.

[31]  W. Domschke,et al.  Antiangiogenic therapy in human gastrointestinal malignancies , 2006, Gut.

[32]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[34]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[35]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[36]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[37]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[38]  Y. Maniwa,et al.  Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. , 1998, Chest.

[39]  Wim Ceelen,et al.  Surgery, wound healing, and metastasis: recent insights and clinical implications. , 2014, Critical reviews in oncology/hematology.

[40]  Oriol Casanovas,et al.  Antiangiogenic therapies: going beyond their limits. , 2014, Cancer discovery.

[41]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[42]  J Edgecumbe,et al.  The birth. , 1978, The Australian nurses' journal. Royal Australian Nursing Federation.